About Andrew Phillips
Andrew Phillips is a director at OnKure Therapeutics.
Form D filings name Andrew Phillips as a director at OnKure.
Andrew Phillips reports to the SEC as a director of 3 public companies, including MoonLake Immunotherapeutics (MLTX) and Enliven Therapeutics (ELVN).
Andrew Phillips first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Phillips in the role, so the role may have started earlier or lasted longer.
OI
OnKure Therapeutics, Inc.
Director
2024 – 2026 · Public company (OKUR)
MI
MoonLake Immunotherapeutics
Director
2022 – 2026 · Public company (MLTX)
EI
Enliven Therapeutics, Inc.
Director
2023 – 2025 · Public company (ELVN)
Key Colleagues at Startups
The people Andrew Phillips works with at each company, as listed on that company's latest Form D.
OnKure, Inc. · Form D, Apr 3, 2023
AP
Anthony Piscopio
Executive officer and director
RC
R. Carruthers
Director
IM
Isaac Manke
Director
NS
Nicholas Saccomano
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
JL
Jason Leverone
Executive officer
KO
Keith Olivia
Secretary